Tight timeline, unstable infrastructure
To launch clinical trials in India starting in March 2025, DKMS needed a stable, secure, and scalable infrastructure in Microsoft Azure on short notice. However, the environment previously set up by another service provider showed weaknesses: unstable and insecure VPN connections, manually distributed VPN profiles, error-prone DNS resolution, and complex certificate management that jeopardized the timeline and the study launch.
Stabilize, automate, secure
A senior cloud infrastructure consultant from adesso therefore quickly analyzed the existing Azure architecture and addressed the biggest risks. The VPN architecture was redesigned, client connections were clearly segmented, VPN profiles were automatically distributed via Microsoft Intune, and the DNS structure was optimized to ensure reliable service availability. At the same time, the entire process surrounding SSL certificates was automated—from creation and secure storage to distribution to virtual machines—with a focus on security, scalability, and operations.
To future-proof remote access for administrators, a security concept for RDP connections was also developed, evaluating a cloud-based option using Microsoft Entra ID and Conditional Access, as well as an on-premises solution with a smart card or YubiKey. Thanks to close collaboration and targeted knowledge transfer, the internal IT team can now securely operate and further develop the new environment.
A cloud that supports the launch of studies and growth
The Azure infrastructure is stable and productive well in advance of the start of studies; all clients are connected centrally and securely; data traffic is controlled via Azure Firewall; remote access works reliably—even during international travel; and support costs have dropped significantly. DKMS now has a future-proof cloud foundation on which additional locations and projects can be built—the technology serves as a reliable foundation for research and studies that ultimately save lives.
We are extremely satisfied with the support we received from adesso for our project. Assistance was provided quickly and efficiently, and competent experts were made available.
Aaron Zedler, Head of IT, DKMS Life Science Lab gGmbH
The DKMS Life Science Lab in Dresden is a subsidiary of DKMS Group gGmbH and ranks among the most innovative laboratories for HLA typing worldwide. Together with the DKMS Foundation India in Bangalore, the organization provides patients with blood cancer worldwide access to potential stem cell donors—and thus a second chance at life.
No matter what phase you are in with your project, we will be happy to advise you and ensure that your project picks up speed.
Business Development Manager
Felix
Tauber
+49 15174310439
